<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A double-blind, placebo controlled, cross-over trial of <z:chebi fb="0" ids="9332">sulfamethoxazole</z:chebi> and <z:chebi fb="0" ids="45924">trimethoprim</z:chebi> was performed in a 62-year-old male patient who suffered from <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> for 25 years </plain></SENT>
<SENT sid="1" pm="."><plain>The patient, with <z:hpo ids='HP_0001251'>cerebellar ataxia</z:hpo>, <z:e sem="disease" ids="C1446219" disease_type="Disease or Syndrome" abbrv="">akinetic-rigid syndrome</z:e> and motor <z:mp ids='MP_0000746'>weakness</z:mp> but without any pyramidal features, had been chair-bound for 3 years before the trial </plain></SENT>
<SENT sid="2" pm="."><plain>Bactrim therapy markedly improved performance on a physical examination which tested standing and gait, as compared to placebo session </plain></SENT>
<SENT sid="3" pm="."><plain>Walker-assisted gait was possible again </plain></SENT>
<SENT sid="4" pm="."><plain>For the first time, evaluation of spatio-temporal contrast sensitivity was performed and also revealed an improvement after Bactrim therapy as compared to placebo </plain></SENT>
<SENT sid="5" pm="."><plain>These results suggest that Bactrim may be effective in degenerative <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological diseases</z:e> and that Bactrim may have an overall effect on neurotransmission rather than solely possessing antispastic properties </plain></SENT>
</text></document>